print this page

Clinical Trials: Infection


A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg every 8 hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities (IRB# BH-12-114)

(Infection, Surgery)
  • Principal Investor
    Patrick Lee, MD
  • Summary

    The purpose of this research study is to see how well a new drug, ceftaroline fosamil, works to treat complicated skin and soft tissue infections (cSSTIs) and how safe it is. In this research study, you will get either the study drug, ceftaroline fosamil or vancomycin and aztreonam.

  • More Information

    Eligibility:

    To participate in this study you must be aged 18 years and older, and have one of the following complicated skin and soft tissue infections (cSSTIs): cellulitis (skin infection), traumatic or surgical wound infection, major skin abscess (collection of pus) or burn infection.

  • Study Site Location
    Baystate Medical Center
  • Contact
    Barbara Burkott, RN, BSN, CCRP
    413.794.1305
    Email

A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 In Patients With Clostridium Difficile Associated Diarrhea (IRB# BH-12-161)

(Infection, Surgery)
  • Principal Investor
    Patrick Lee, MD
  • Summary

    The purpose of this research study is to look at the safety and effectiveness of the study drug or oral vancomycin against Clostridium difficile Associated Diarrhea (CDAD). 

  • More Information

    Eligibility:

    To participate in the study you must be age 18-89, have a positive C. difficile toxin test and have 3 unformed bowel movements.

  • Study Site Location
    Baystate Medical Center
  • Contact
    Barbara Burkott, RN, BSN, CCRP
    413.794.1305
    Email